ARCHIVES

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

This article is from The Cancer Letter archive.

Vol. 32 No. 36 | October 13, 2006

Download PDF Visit The Full Archive

Related Articles

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

Also Stillman named director, Cold Spring Harbor, Watson is chancellor.

December 12, 2003

In Brief: Thomas King Names Special Assistant To Lombardi Center Director; John MacDonald Takes U. Ky. Job

March 30, 1984

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

July 9, 1976

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012